Advances and Progress in Drug Design
Conference - London, United Kingdom
SMi are proud to present the 13th annual *Advances and Progress in Drug Design *conference, convening in Central London on Monday 17 and Tuesday 18 February 2014.
This exciting event will focus on new approaches and will offer attendees the chance to hear from leading industry experts on lead optimisation strategies, SBDD and FBDD.
Advances and Progress in Drug Design will build on the success of our previous events and bring together a unique mix of senior executives from all over industry and academia and will be an unrivaled forum for problem-solving discussion and debate.
Key Speakers for 2014
• John Mathias, Head of Medicinal Chemistry – Inflammation & Remodelling, Pfizer
• Sudharsan Sridharan, Scientist, MedImmune
• Tom Heightman, Senior Director, Astex Pharmaceuticals
• Amaury Ernesto Fernandez-Montalvan, Lab Head, High Throughput Screening, Bayer HealthCare Pharmaceuticals
• Karl-Heinz Baringhaus, Head of R&D, Sanofi-Aventis
• Andreas Kuglstatter, Head of Protein Crystallography, Roche Chemische Unternehmungen AG
• Dr Neil Press, Director, Novartis
• Paul Labute, CEO, Chemical Computing Group
• Andrea Bortolato, Senior Computational Chemistry, Heptares Therapeutics
• Paul Brennan, Group Head/PI, Nuffield Department of Medicine
Organization: SMi Group
(Courtesy of 13th Annual Advances and Progress in Drug Design Conference's logo, via eventyard.net)
Advances and Progress in Drug Design
Mon, Feb 17, 2014 - Tue, Feb 18, 2014
Marriott Regents Park Hotel
128 King Henry's Road, London, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.